ANVISA Resolution 1018/2026 Updates Foreign Trade Regulatory Control Framework

ANVISA issued Resolution 1018/2026 introducing amendments to RDC 977/2025, reinforcing regulatory oversight and administrative control in foreign trade operations involving goods subject to health surveillance. The update enhances compliance requirements, operational control, and regulatory monitoring of imported and exported health products.